Science Explorer Back to mapMap
Discussion
Researcher · PARI (Germany) · Germany

Albert Bucholski

Albert Bucholski publishes mostly in Pulmonary and Respiratory Medicine, Pharmaceutical Science and Health, Toxicology and Mutagenesis, on topics such as Inhalation and Respiratory Drug Delivery, Neonatal Respiratory Health Research and Cystic Fibrosis Research Advances.

OpenAlex
World rank
#3,781,478
of 7,710,434 ranked researchers
Rank in Germany
#189,616
of 364,343
Works
15
Citations
282
Citations per work
18.8
h-index
6
i10-index 6Top 78% in Pulmonary and Respiratory Medicine
Albert Bucholski

What does Albert Bucholski research?

Albert Bucholski's work is mostly in Medicine (51%), Pharmacology, Toxicology and Pharmaceutics (10%), Environmental Science (8%).

Health Sciences: 8 works · 51.4% of their workMedicine: 8 works · 51.4% of their workPulmonary and Respiratory Medicine: 7 works · 46.2% of their workImmunology and Allergy: 0 works · 2.6% of their workSurgery: 0 works · 2.6% of their workEverything else: 4 works · 28.0% of their workLife Sciences: 2 works · 12.9% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 10.3% of their workPharmaceutical Science: 2 works · 10.3% of their workBiochemistry, Genetics and Molecular Biology: 0 works · 2.6% of their workMolecular Medicine: 0 works · 2.6% of their workPhysical Sciences: 1 works · 7.7% of their workEnvironmental Science: 1 works · 7.7% of their workHealth, Toxicology and Mutagenesis: 1 works · 7.7% of their workTHEIR WORKAlbert Bucholski15works
Life Sciences13%Physical Sciences8%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine851.4%
  2. Everything else428.0%
    1. Pharmacology, Toxicology and Pharmaceutics210.3%
    2. Biochemistry, Genetics and Molecular Biology02.6%
    1. Environmental Science17.7%
  1. 1Pulmonary and Respiratory Medicine46% of their works
  2. 2Pharmaceutical Science10% of their works
  3. 3Health, Toxicology and Mutagenesis8% of their works
  4. 4Molecular Medicine3% of their works
  5. 5Immunology and Allergy3% of their works
  6. 6Surgery3% of their works

Research topics

Which keywords describe Albert Bucholski's research?

The keywords of their largest research topics: Nanoparticles, Inhaler Devices, Pulmonary Drug Delivery, Bronchopulmonary Dysplasia, Preterm Infants, CFTR, Cystic Fibrosis and Chitosan.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Nanoparticles122 topics
  2. Inhaler Devices101 topic
  3. Pulmonary Drug Delivery101 topic
  4. Bronchopulmonary Dysplasia41 topic
  5. Preterm Infants41 topic
  6. CFTR31 topic
  7. Cystic Fibrosis31 topic
  8. Chitosan21 topic
  9. Cyclodextrins21 topic
  10. Mucosal21 topic
  11. Solid Dispersions21 topic
  12. Antibiotic Resistance11 topic
  13. Atmospheric Aerosols11 topic
  14. Biopharmaceuticals11 topic
  15. Black Carbon11 topic
  16. Multidrug-Resistant Bacteria11 topic
  17. Protein Aggregation11 topic

Where does Albert Bucholski work?

Albert Bucholski's main affiliation in the publication record is PARI (Germany), Germany.

How many publications and citations does Albert Bucholski have?

OpenAlex counts 15 works and 282 citations for Albert Bucholski, an h-index of 6, ranking #3,781,478 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Albert Bucholski. Posts are plain text and can be reported.